PLX closed Thursday's trading at 0.55, down 3.48%. In after-hours, the stock was up 11.71% to $0.64. ZELTIQ Aesthetics Inc.'s (ZLTQ) fat freezing method CoolSculpting has now received FDA clearance to address another body area - upper arms. The company ...
RTTNews · 1y
Protalix BioTherapeutics, Inc. PLX announced that the European Commission (“EC ... But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
San Jose-based Integrated Device Technology reached a deal on April 30 to purchase PLX Technology for cash and stock totaling $330 million — and the two companies have been trying to win Federal Trade Commission approval since then. “The commission is ...
Avago expects the acquisition to add immediately to non-GAAP earnings per share and anticipates “driving the PLX business to a level consistent with Avago’s long term business model by the end of fiscal year 2015.” Avago’s stock is up 95% over the ...
This is the second time in three months that a patient suffering from bone marrow failure was successfully treated with its PLX cells, the Israeli company ... failed bone marrow transplants, sending its stock up 32 percent.
Fox News · 5y
One stock that might be an intriguing choice for investors right now is Protalix BioTherapeutics, Inc. (PLX). This is because this security in the Healthcare industry space is seeing solid earnings estimate revision activity, and is in great company from a ...
HOUSTON (AP) _ PLx Pharma Inc. (PLXP) on Thursday reported a loss of $ ... using data from Zacks Investment Research. Access a Zacks stock report on PLXP at https://www.zacks.com/ap/PLXP
Yahoo! · 6mon
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLXP at https://www.zacks.com/ap/PLXP Keywords: PLx Pharma, Earnings Report